Cellid Co. Ltd (299660) - Total Liabilities

Latest as of December 2025: ₩36.66 Billion KRW ≈ $24.85 Million USD

Based on the latest financial reports, Cellid Co. Ltd (299660) has total liabilities worth ₩36.66 Billion KRW (≈ $24.85 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 299660 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cellid Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Cellid Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Cellid Co. Ltd.

Cellid Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Cellid Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
SuperCom Ltd F:50S	Germany	€28.23 Million
Chosun Welding KO:120030	Korea	₩11.60 Billion
Iris Business Services Limited NSE:IRIS	India	Rs519.80 Million
Gemfields Group Limited F:5PH	Germany	€188.83 Million
Hyweb Technology Co Ltd TWO:5212	Taiwan	NT$811.63 Million
Upsales Technology AB ST:UPSALE	Sweden	Skr81.56 Million
Evrofarma SA AT:EVROF	Greece	€34.79 Million
CSL Finance Limited NSE:CSLFINANCE	India	Rs8.10 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Cellid Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Cellid Co. Ltd (299660) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cellid Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cellid Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Cellid Co. Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩36.66 Billion ≈ $24.85 Million	+47.34%
2024-12-31	₩24.88 Billion ≈ $16.86 Million	+6.22%
2023-12-31	₩23.43 Billion ≈ $15.88 Million	+0.04%
2022-12-31	₩23.42 Billion ≈ $15.87 Million	+20.12%
2021-12-31	₩19.50 Billion ≈ $13.21 Million	+826.53%
2020-12-31	₩2.10 Billion ≈ $1.43 Million	+77.41%
2019-12-31	₩1.19 Billion ≈ $803.76K	+64.58%
2018-12-31	₩720.63 Million ≈ $488.36K	-93.13%
2017-12-31	₩10.49 Billion ≈ $7.11 Million	+161.36%
2016-12-31	₩4.01 Billion ≈ $2.72 Million	+114.39%
2015-12-31	₩1.87 Billion ≈ $1.27 Million	--

About Cellid Co. Ltd

KQ:299660 Korea Biotechnology

Market Cap

$52.38 Million

₩77.30 Billion KRW

Market Cap Rank

#21794 Global

#1317 in Korea

Share Price

₩2620.00

Change (1 day)

-9.19%

52-Week Range

₩1025.00 - ₩4110.00

All Time High

₩127128.20